Opus Genetics develops gene therapies for inherited retinal diseases that can cause severe vision loss. It last closed at $3.99 on Nov 20, down 2.21% on the day. The next earnings report for IRD is expected around Thu, Feb 18, 2027, after the close. For the quarter ended Sep 2026, IRD reported EPS of -$0.46 on revenue of $1.1M, with revenue down 63.1% from a year ago. Over its last 8 reports the stock moved an average of 3.5% the session after earnings. Over the last 12 months IRD insiders bought $324K of stock on the open market and sold $19.7M, according to SEC Form 4 filings.
AI Auto Pilots
Is IRD in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold IRD.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on IRDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
IRD · as of the Nov 20 close · updated each morning
Turning down
The stock sits between its 20 and 50 day averages. It is 8% below its 200 day average, so the longer trend is down. Momentum is improving (RSI 48). The nearest support is the Pivot at $3.98, and the nearest resistance the Pivot R1 at $4.06.
Short trendBearish
Long trendNeutral
MomentumImproving
StretchNormal
VolatilityNormal, 7.2%/day
Key levels
$7.0752 week high+77.2%
$4.3550 day average+9.0%
$4.30200 day average+7.8%
$4.21Swing high (Oct 21)+5.5%
$4.12100 day average+3.3%
$4.06Pivot R1+1.8%
$3.99Last close
$3.98Pivot−0.3%
$3.9420 day average−1.3%
$3.91Pivot S1−2.0%
$3.90Swing low (May 27)−2.3%
$1.8652 week low−53.4%
Indicators
RSI (14)
47.76
Middle of its range
Neutral
MACD
-0.03
Above its signal line
Bullish
Stochastic
43.0
Middle of its range
Neutral
ADX (14)
8.7
No clear trend
Williams %R
-68.0
Oversold below −80, overbought above −20
Neutral
CCI (20)
15.9
Oversold below −100, overbought above 100
Neutral
Rate of change
−4.5%
Change over 10 sessions
Bearish
ATR (14)
$0.29
Typical daily range, 7.2% of price
MA 10Below
MA 20Above
MA 50Below
MA 100Below
MA 200Below
Moving sideways
Short trendNeutral
Long trendBullish
MomentumFading
StretchNormal
VolatilityHigh, 19.3%/day
Key levels
$7.0752 week high+77.2%
$4.3550 day average+9.0%
$4.30200 day average+7.8%
$4.21Swing high (Oct 21)+5.5%
$4.12100 day average+3.3%
$4.06Pivot R1+1.8%
$3.99Last close
$3.98Pivot−0.3%
$3.9420 day average−1.3%
$3.91Pivot S1−2.0%
$3.90Swing low (May 27)−2.3%
$1.8652 week low−53.4%
Indicators
RSI (14)
48.94
Middle of its range
Neutral
MACD
0.02
Below its signal line
Bearish
Stochastic
21.4
Middle of its range
Neutral
ADX (14)
24.3
Weak trend
Williams %R
-80.2
Oversold below −80, overbought above −20
Oversold
CCI (20)
-19.3
Oversold below −100, overbought above 100
Neutral
Rate of change
−33.9%
Change over 10 sessions
Bearish
ATR (14)
$0.77
Typical daily range, 19.3% of price
MA 10Below
MA 20Below
MA 50Above
MA 100Above
MA 200Above
What happened before, for IRD
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how IRD did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow IRD usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for IRDHow many large options trades hit IRD, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in IRD in the last 90 days.
From SEC Form 4 filings by IRD's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether IRD is in one of them and how their past IRD trades turned out.
Opus Genetics is a biopharmaceutical company based in Durham, North Carolina. It is developing gene therapies meant to restore vision and prevent blindness in people with inherited retinal diseases, including Leber congenital amaurosis, bestrophinopathy and retinitis pigmentosa. The company is also developing a prescription eye solution for other ophthalmic conditions, and its target patients are people facing severe, often early-onset, eye disorders.